Latest News & Updates
Breaking News
7 hours ago
Simantini Singh Deo
Other trending news you may like to read
Theriva Biologics Gets Positive EMA Scientific Advice For Phase 3 Trial Design Of VCN-01 In Metastatic Pancreatic Ductal Adenocarcinoma
Theriva secures EMA CHMP guidance endorsing a Phase 3 study of VCN-01 with chemotherapy for metastatic PDAC.
Simantini Singh Deo
SELLAS Life Sciences Issues Update On Pivotal Phase 3 REGAL Trial Evaluating Galinpepimut-S (GPS) For Acute Myeloid Leukemia
SELLAS shares progress on the Phase 3 REGAL study of GPS in acute myeloid leukemia, with overall survival events still accruing.
Simantini Singh Deo
Praxis Precision Medicines Wins FDA Breakthrough Therapy Designation For Ulixacaltamide, A Selective T-Type Calcium Channel Inhibitor For Essential Tremor
Praxis receives FDA Breakthrough Therapy Designation for ulixacaltamide, a novel T-type calcium channel inhibitor for essential tremor.
Simantini Singh Deo
China Accepts HUTCHMED’s NDA For Fanregratinib And Grants Priority Review For FGFR2-Positive Advanced Intrahepatic Cholangiocarcinoma
HUTCHMED secures China priority review for fanregratinib to treat FGFR2-altered intrahepatic cholangiocarcinoma.
Simantini Singh Deo
